Solventum Corp. (SOLV) support and resistance · P/E 9.1, rev $8.25B
Solventum Corp. (SOLV) is a medical instruments & supplies company listed on NYSE.
This page maps Solventum Corp. (SOLV) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported SOLV revenue for 2024-12-31 was $8.25B. Net income was $479.0M. Revenue was up 0.7% from 2023-12-31 to 2024-12-31. SOLV currently screens at market cap $12.91B and trailing P/E 9.1.
SOLV currently screens at market cap $12.91B and trailing P/E 9.1. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new SOLV 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the SOLV quote page for the session range and the stock page for the full model.
Not investment advice.